Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial

Early evidence suggests the efficacy of voriconazole for chronic pulmonary aspergillosis (CPA). We conducted a prospective, open, multicenter trial to evaluate the efficacy and safety of voriconazole for proven CPA in minimally or non-immunocompromised patients. Patients had CPA confirmed by chest c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadranel, J., Philippe, B., Hennequin, C., Bergeron, A., Bergot, E., Bourdin, A., Cottin, V., Jeanfaivre, T., Godet, C., Pineau, M., Germaud, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479377/
https://www.ncbi.nlm.nih.gov/pubmed/22782438
http://dx.doi.org/10.1007/s10096-012-1690-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479377/
https://www.ncbi.nlm.nih.gov/pubmed/22782438
http://dx.doi.org/10.1007/s10096-012-1690-y

Ejemplares similares